Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.056
▾0.00 (0.00%)
Last trade: 01/11, 5:34PM
Market cap
$12.33m
Market closed
Talk to Cellmid Limited directly.
Sign up to their Investor Hub for direct access to the Cellmid Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Cellmid Limited (CDY) is an Australian life sciences company with lead programs in multiple disease indications. The Company, through its wholly owned subsidiaries, Lyramid, Kinera and Advangen, develops and markets in novative novel therapies and diagnostic tests for fibrotic diseases, cancer, ischemic diseases of the heart and hair loss. They operate through two business segment Midikine and Consumer health.
Address
Suite 204, Level 2/55 Clarence St, Sydney NSW 2000, Australia
Website
News
Announcements
Filter
Announcement | T+2 Movement | Date |
---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.056
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
Company | Market Cap | ||
---|---|---|---|
Support
Live Chat
Markets